116 related articles for article (PubMed ID: 1705817)
1. Mode of action of 5'-linked cholesteryl phosphorothioate oligodeoxynucleotides in inhibiting syncytia formation and infection by HIV-1 and HIV-2 in vitro.
Stein CA; Pal R; DeVico AL; Hoke G; Mumbauer S; Kinstler O; Sarngadharan MG; Letsinger RL
Biochemistry; 1991 Mar; 30(9):2439-44. PubMed ID: 1705817
[TBL] [Abstract][Full Text] [Related]
2. Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4.
Stein CA; Neckers LM; Nair BC; Mumbauer S; Hoke G; Pal R
J Acquir Immune Defic Syndr (1988); 1991; 4(7):686-93. PubMed ID: 1711118
[TBL] [Abstract][Full Text] [Related]
3. Effect of Evans blue and trypan blue on syncytia formation and infectivity of human immunodeficiency virus type I and type II in vitro.
Pal R; Mumbauer S; Hoke G; Larocca R; Myers C; Sarngadharan MG; Stein CA
AIDS Res Hum Retroviruses; 1991 Jun; 7(6):537-43. PubMed ID: 1718343
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
[TBL] [Abstract][Full Text] [Related]
5. Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro.
Montefiori DC; Sobol RW; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W; Modliszewski A; Robinson WE; Mitchell WM
Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7191-4. PubMed ID: 2476814
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidine.
Marshall WS; Beaton G; Stein CA; Matsukura M; Caruthers MH
Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6265-9. PubMed ID: 1378623
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587.
Koup RA; Merluzzi VJ; Hargrave KD; Adams J; Grozinger K; Eckner RJ; Sullivan JL
J Infect Dis; 1991 May; 163(5):966-70. PubMed ID: 1708400
[TBL] [Abstract][Full Text] [Related]
8. Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320).
Buckheit RW; Roberson JL; Lackman-Smith C; Wyatt JR; Vickers TA; Ecker DJ
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1497-506. PubMed ID: 7888204
[TBL] [Abstract][Full Text] [Related]
9. 5'-Cholesteryl-phosphorothioate oligodeoxynucleotides: potent inhibition of methotrexate transport and antagonism of methotrexate toxicity in cells containing the reduced-folate carrier.
Henderson GB; Stein CA
Nucleic Acids Res; 1995 Sep; 23(18):3726-31. PubMed ID: 7479003
[TBL] [Abstract][Full Text] [Related]
10. Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus.
Ichimura H; Levy JA
Virology; 1995 Aug; 211(2):554-60. PubMed ID: 7544050
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
[TBL] [Abstract][Full Text] [Related]
12. Effect of structural variations in cholesteryl-conjugated oligonucleotides on inhibitory activity toward HIV-1.
Farooqui F; Sarin PS; Sun D; Letsinger RL
Bioconjug Chem; 1991; 2(6):422-6. PubMed ID: 1805939
[TBL] [Abstract][Full Text] [Related]
13. Antiviral action of oligodeoxyguanylic acids against human immunodeficiency virus type 1.
Fujihashi T; Sakata T; Kaji A; Kaji H
AIDS Res Hum Retroviruses; 1995 Apr; 11(4):461-71. PubMed ID: 7543270
[TBL] [Abstract][Full Text] [Related]
14. The synthesis of nucleoside 5'-O-(1,1-dithiotriphosphates).
Okruszek A; Olesiak M; Balzarini J
J Med Chem; 1994 Oct; 37(22):3850-4. PubMed ID: 7525960
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HIV-1 replication and activation of RNase L by phosphorothioate/phosphodiester 2',5'-oligoadenylate derivatives.
Sobol RW; Henderson EE; Kon N; Shao J; Hitzges P; Mordechai E; Reichenbach NL; Charubala R; Schirmeister H; Pfleiderer W
J Biol Chem; 1995 Mar; 270(11):5963-78. PubMed ID: 7890727
[TBL] [Abstract][Full Text] [Related]
16. Combinatorial selection, inhibition, and antiviral activity of DNA thioaptamers targeting the RNase H domain of HIV-1 reverse transcriptase.
Somasunderam A; Ferguson MR; Rojo DR; Thiviyanathan V; Li X; O'Brien WA; Gorenstein DG
Biochemistry; 2005 Aug; 44(30):10388-95. PubMed ID: 16042416
[TBL] [Abstract][Full Text] [Related]
17. Towards the selection of phosphorothioate aptamers optimizing in vitro selection steps with phosphorothioate nucleotides.
Andreola ML; Calmels C; Michel J; Toulmé JJ; Litvak S
Eur J Biochem; 2000 Aug; 267(16):5032-40. PubMed ID: 10931185
[TBL] [Abstract][Full Text] [Related]
18. Study of viral replication in HIV-1-infected CEM T-cell subclones which are reduced in their ability to form syncytia.
Gruber MF; Hewlett IK; Simms T; Vujcic L; Manischewitz J; Golding H
AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1139-46. PubMed ID: 1380260
[TBL] [Abstract][Full Text] [Related]
19. Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formation.
Baba M; Schols D; De Clercq E; Pauwels R; Nagy M; Györgyi-Edelényi J; Löw M; Görög S
Antimicrob Agents Chemother; 1990 Jan; 34(1):134-8. PubMed ID: 2327749
[TBL] [Abstract][Full Text] [Related]
20. DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity.
Andreola ML; Pileur F; Calmels C; Ventura M; Tarrago-Litvak L; Toulmé JJ; Litvak S
Biochemistry; 2001 Aug; 40(34):10087-94. PubMed ID: 11513587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
